HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway.
about
Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascade.Prevalence and risk factors of bone metastasis and skeletal related events in patients with primary breast cancer in Japan.TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis.
P2860
HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
HGFK1 inhibits bone metastasis ...... K1/p38 MAPK signaling pathway.
@en
HGFK1 inhibits bone metastasis ...... K1/p38 MAPK signaling pathway.
@nl
type
label
HGFK1 inhibits bone metastasis ...... K1/p38 MAPK signaling pathway.
@en
HGFK1 inhibits bone metastasis ...... K1/p38 MAPK signaling pathway.
@nl
prefLabel
HGFK1 inhibits bone metastasis ...... K1/p38 MAPK signaling pathway.
@en
HGFK1 inhibits bone metastasis ...... K1/p38 MAPK signaling pathway.
@nl
P2093
P2860
P356
P1433
P1476
HGFK1 inhibits bone metastasis ...... K1/p38 MAPK signaling pathway.
@en
P2093
P2860
P2888
P304
P356
10.1038/CGT.2012.38
P577
2012-07-06T00:00:00Z